Drug
Quetiapine Extended Release
Quetiapine Extended Release is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph phase_3
2
50%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 42 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Brexpiprazole in Patients With Acute Schizophrenia
NCT01810380
completedphase_3
Quetiapine Extended Release Depression Symptoms
NCT00640562
completedphase_4
Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
NCT00723970
completedphase_4
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
NCT00926393
Clinical Trials (4)
Showing 4 of 4 trials
NCT01810380Phase 3
Brexpiprazole in Patients With Acute Schizophrenia
NCT00640562Phase 3
Quetiapine Extended Release Depression Symptoms
NCT00723970Phase 4
Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
NCT00926393Phase 4
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4